Document Detail

Initial experience with the medtronic ADVANTAGE valve prosthesis in the mitral position--clinical outcome and analysis of complications.
MedLine Citation:
PMID:  17410499     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The Medtronic ADVANTAGE prosthetic heart valve is a bileaflet mechanical heart valve which has two main design modifications. The prosthesis has an enlarged central orifice to improve blood flow characteristics and an asymmetric butterfly pivot recess with expanded outflow component designed to enhance the blood flow washing through the pivot region. This report summarizes the initial experience with 55 patients who underwent isolated mitral valve replacement. METHODS: We prospectively followed 55 patients undergoing mitral valve replacement with the Medtronic ADVANTAGE prosthesis in a single center study. All patients were operated on via a median sternotomy and a left atrial approach. RESULTS: The age of the patients at implant ranged from 42 years to 77 years with a mean of 61.8 years. Forty-five percent of the patients were male. Seventy-five percent of the patients were in NYHA functional class III or IV prior to valve replacement. The diameters of the implanted prostheses were as follows: 25 mm in 2 patients, 27 mm in 12 patients, 29 mm in 20 patients, and 31 mm in 21 patients. Coronary artery bypass grafting was performed with valve replacement in 16.4 % of patients and additional tricuspid repair in 10.9 %. After one year, 97.6 % and after two years 100 % of the included patients were in NYHA functional class I or II. All patients had Coumadin (warfarin) therapy postoperatively with a target INR range of 2.5 to 3.5, or 3.0 to 4.0. There were 4 thromboembolic events (7.3 %) in the early period and 2 late events (2.6 %). Episodes of valve thrombosis were not seen during the follow-up, which consisted of 76.5 patient years. The hemodynamic performance was favorable and within clinically acceptable ranges. The incidence of valve-related mortality and morbidity in this preliminary study was extremely low, indicating good clinical results comparable to those reported for other bileaflet valves. CONCLUSION: The ADVANTAGE valve is a safe and effective option for mitral valve replacement with a very low incidence of valve-related complications.
N Reiss; D Seifert; H Koertke; A Hoffmann-Koch; G Kleikamp; A Bairaktaris; R Koerfer
Related Documents :
556399 - Influence of preoperative left ventricular function on results of homograft replacement...
19379889 - Perioperative risks and outcomes of atrioventricular valve surgery in conjunction with ...
2709859 - The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy. experienc...
11843519 - Decision-making in the choice of heart valve for replacement in patients aged 60-70 yea...
16607899 - Valve surgery in octogenarians: a safe option with good medium-term results.
831009 - Heart valve replacement with the ionescu-shiley pericardial xenograft.
16215379 - Open lung ventilation improves functional residual capacity after extubation in cardiac...
8369579 - Cyclosporin versus etretinate: italian multicenter comparative trial in severe plaque-f...
17978829 - Tonsillectomy à chaud for quinsy: revisited.
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  The Thoracic and cardiovascular surgeon     Volume:  55     ISSN:  0171-6425     ISO Abbreviation:  Thorac Cardiovasc Surg     Publication Date:  2007 Apr 
Date Detail:
Created Date:  2007-04-05     Completed Date:  2007-06-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7903387     Medline TA:  Thorac Cardiovasc Surg     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  149-55     Citation Subset:  IM    
Service de Chirurgie Thoracique et Cardiovasculaire, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Heart Valve Prosthesis*
Heart Valve Prosthesis Implantation* / adverse effects,  instrumentation,  mortality
Kaplan-Meiers Estimate
Middle Aged
Mitral Valve*
Prospective Studies
Prosthesis Design

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Update on the contribution of galactomannan for the diagnosis of invasive aspergillosis.
Next Document:  Mechanical aortic and mitral valve replacement in infants and children.